Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

AristaMD arranges $18m series B

AristaMD arranges $18m series B

Apr 1, 2020 • Robert Lavine

AristaMD, developer of a remote diagnostics system, raised $18m in a round backed by CU Healthcare Innovation Fund.

AristaMD, a US-based medical diagnostics technology developer, raised $18m in a series B round yesterday backed by CU Healthcare Innovation Fund, an affiliate of University of Colorado Anschutz Medical Campus.
Stanford University-linked health system Stanford Health Care also took part in the round, as did venture capital firm Avalon Ventures. The round was co-led by Cigna Ventures and MemorialCare Innovation Fund, subsidiaries of healthcare provider MemorialCare Health System and health services firm Cigna.
AristaMD has created a telehealth system called eConsult that enables primary care providers to conduct patient assessments in collaboration with experts at external locations. The cash will support its expansion throughout the US.
The company has now secured a total of $46.3m in debt and equity financing, according to press releases and regulatory filings.
The total includes $11m that came in a 2016 series A round led by Avalon Ventures and backed by Correlation Ventures. Philadelphia College of Osteopathic Medicine’s Primary Care Innovation Fund is also an investor.
Tom Richards, Cigna’s global lead for strategy and business development, said: “Cigna is squarely focused on improving access to affordable, predictable and simple care – quickly and efficiently connecting customers to the most effective health care providers, how, when and where they need it.
“Our partnership with AristaMD, and its virtual-first solution, will accelerate how we deliver on that promise, working together to drive greater connectivity between primary care providers and extensive networks of specialists to improve outcomes and lower costs for the people we serve.”
– A version of this article first appeared on our sister site, Global Corporate Venturing.

AristaMD, developer of a remote diagnostics system, raised $18m in a round co-led by Cigna Ventures and MemorialCare Innovation Fund.

Subsidiaries of healthcare provider MemorialCare Health System and health services firm Cigna co-led an $18m series B round for US-based medical diagnostics technology developer AristaMD yesterday.

Cigna Ventures and MemorialCare Innovation Fund were joined by CU Healthcare Innovation Fund, an affiliate of University of Colorado Anschutz Medical Campus, in addition to medical clinic Stanford Health Care and venture capital firm Avalon Ventures.

AristaMD has created a telehealth system called eConsult that enables primary care providers to conduct patient assessments in collaboration with experts at external locations. The cash will support its expansion throughout the US.

The company has now secured a total of $46.3m in debt and equity financing according to press releases and regulatory filings.

The total includes $11m that came in a 2016 series A round led by Avalon Ventures and backed by Correlation Ventures. Philadelphia College of Osteopathic Medicine’s Primary Care Innovation Fund is also an investor.

Tom Richards, Cigna’s global lead for strategy and business development, said: “Cigna is squarely focused on improving access to affordable, predictable and simple care – quickly and efficiently connecting customers to the most effective health care providers, how, when and where they need it.

“Our partnership with AristaMD, and its virtual-first solution, will accelerate how we deliver on that promise, working together to drive greater connectivity between primary care providers and extensive networks of specialists to improve outcomes and lower costs for the people we serve.”

Robert Lavine

Robert Lavine is special features editor for Global Venturing.

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here